secwatch.observer — SEC 8-K summary
======================================

Issuer:     enGene Therapeutics Inc. (ENGN)
CIK:        0001980845
Form:       8-K
Filed at:   2024-09-05T23:59:59+00:00
Accession:  0000950170-24-103727
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

enGene Holdings updates corporate presentation; no specific operational or financial changes disclosed
--------------------------------------------------------------------------------

- Corporate presentation dated September 5, 2024 furnished as Exhibit 99.1.
- Presentation titled 'Non-Viral Genetic Medicine' — no new pipeline or financial data provided in this filing.
- No material events such as earnings, leadership changes, or financing announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1980845/000095017024103727/0000950170-24-103727-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1980845/000095017024103727/engn-20240905.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-103727

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer